Yükleniyor... / Loading...

Neurofibromatosis Type 2 — Gene Therapy & Clinical Trials | FollowGene

Features Diseases How It Works?Approved TherapiesSign In

The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Home/Diseases/Neurofibromatosis Type 2

Neurofibromatosis Type 2

Prevalence: 1/60000

oncologic

Official·OMIM:101000 Official·ORPHA637

Bilateral vestibular schwannoma due to NF2 gene mutations.

Associated Genes

NF2Neurofibromin 2

Chromosome 22Autosomal Dominant

FollowGene

Clinical trial tracking for CRISPR, gene therapy, and rare genetic diseases — a reliable source of information for patients, families, and researchers.

Links

About Us
Blog
Contact

Legal

FollowGene does not provide medical advice. The information here is for informational purposes only. Always consult a healthcare professional for your health decisions.

© 2026 FollowGene. All rights reserved.

Privacy Policy Terms of Use